BRK-B vs EOD

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.

The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating critical weakness in traditional financial health metrics. However, this is contrasted by a strong valuation profile, with the current price of $6.31 trading at a significant discount to its intrinsic value of $9.87 and a very low P/E of 4.48. While long-term price performance is robust (5Y +85.8%), the current technical trend is heavily bearish (10/100). The asset functions as a high-yield income vehicle rather than a growth company, making traditional corporate health scores misleading but mandatory for this risk assessment.